Floatz logo

msc11fcd

Neoplasms, Germ Cell and Embryonal

CHA UniversityCell therapyPhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

25 Active assets in the Neoplasms, Germ Cell and Embryonal cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
M.D. Anderson Cancer Center
Phase 3BB
ETOPOSIDE
Nabil Adra
Phase 3BB
Pembrolizumab
Hoffmann-La Roche
Phase 3BB
CIS-DIAMMINEDICHLOROPLATINUM II
Hoffmann-La Roche
Phase 3BB
Carboplatin
Hoffmann-La Roche
Phase 3BB

View all 48 →

Same molecule, other indications

msc11fcd is also rated in:

gliosarcomaDormant
CCC
Indicative ·
52 / 100
View asset →
brain neoplasmDormant
CCC
Indicative ·
52 / 100
View asset →
glioblastomaDormant
CCC
Indicative ·
49 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →